Literature DB >> 27133823

A recurrent immunophenotype at diagnosis independently identifies high-risk pediatric acute myeloid leukemia: a report from Children's Oncology Group.

L Eidenschink Brodersen1, T A Alonzo2,3, A J Menssen1, R B Gerbing2, L Pardo1, A P Voigt1, S B Kahwash4, B Hirsch5, S Raimondi6, A S Gamis2,7, S Meshinchi2,8, M R Loken1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27133823      PMCID： PMC5136463          DOI： 10.1038/leu.2016.119

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.

Authors:  Michael R Loken; Todd A Alonzo; Laura Pardo; Robert B Gerbing; Susana C Raimondi; Betsy A Hirsch; Phoenix A Ho; Janet Franklin; Todd M Cooper; Alan S Gamis; Soheil Meshinchi
Journal:  Blood       Date:  2012-05-30       Impact factor: 22.113

2.  CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.

Authors:  Mirjana Urosevic; Curdin Conrad; Jivko Kamarashev; Kenji Asagoe; Antonio Cozzio; Günter Burg; Reinhard Dummer
Journal:  Hum Pathol       Date:  2005-09       Impact factor: 3.466

3.  Hematopoietic cell transplantation in high-risk childhood acute myelogenous leukemia.

Authors:  Soheil Meshinchi
Journal:  Biol Blood Marrow Transplant       Date:  2013-07       Impact factor: 5.742

Review 4.  Biology, risk stratification, and therapy of pediatric acute leukemias: an update.

Authors:  Ching-Hon Pui; William L Carroll; Soheil Meshinchi; Robert J Arceci
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

5.  Clinical implications of FLT3 mutations in pediatric AML.

Authors:  Soheil Meshinchi; Todd A Alonzo; Derek L Stirewalt; Michel Zwaan; Martin Zimmerman; Dirk Reinhardt; Gertjan J L Kaspers; Nyla A Heerema; Robert Gerbing; Beverly J Lange; Jerald P Radich
Journal:  Blood       Date:  2006-08-15       Impact factor: 22.113

Review 6.  Pediatric acute myeloid leukemia: biology and therapeutic implications of genomic variants.

Authors:  Katherine Tarlock; Soheil Meshinchi
Journal:  Pediatr Clin North Am       Date:  2014-10-29       Impact factor: 3.278

7.  CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis.

Authors:  D Raspadori; D Damiani; M Lenoci; D Rondelli; N Testoni; G Nardi; C Sestigiani; C Mariotti; S Birtolo; M Tozzi; F Lauria
Journal:  Leukemia       Date:  2001-08       Impact factor: 11.528

8.  The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score.

Authors:  O Legrand; J Y Perrot; M Baudard; A Cordier; R Lautier; G Simonin; R Zittoun; N Casadevall; J P Marie
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

9.  HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.

Authors:  A A Scott; D R Head; K J Kopecky; F R Appelbaum; K S Theil; M R Grever; I M Chen; M H Whittaker; B B Griffith; J D Licht
Journal:  Blood       Date:  1994-07-01       Impact factor: 22.113

10.  Outcome of pediatric patients with acute myeloid leukemia (AML) and -5/5q- abnormalities from five pediatric AML treatment protocols: a report from the Children's Oncology Group.

Authors:  Donna L Johnston; Todd A Alonzo; Robert B Gerbing; Betsy Hirsch; Nyla A Heerema; Yaddanapudi Ravindranath; William G Woods; Beverly J Lange; Alan S Gamis; Susana C Raimondi
Journal:  Pediatr Blood Cancer       Date:  2013-08-30       Impact factor: 3.167
View more
  12 in total

Review 1.  Opportunities for immunotherapy in childhood acute myeloid leukemia.

Authors:  Adam J Lamble; Sarah K Tasian
Journal:  Blood Adv       Date:  2019-11-26

2.  Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.

Authors:  Laura M Pardo; Andrew P Voigt; Todd A Alonzo; Elisabeth R Wilson; Robert B Gerbing; Dana J Paine; Fangyan Dai; Andrew J Menssen; Susana C Raimondi; Betsy A Hirsch; Alan S Gamis; Soheil Meshinchi; Denise A Wells; Lisa Eidenschink Brodersen; Michael R Loken
Journal:  Cytometry B Clin Cytom       Date:  2019-07-11       Impact factor: 3.058

Review 3.  Opportunities for immunotherapy in childhood acute myeloid leukemia.

Authors:  Adam J Lamble; Sarah K Tasian
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

4.  CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group.

Authors:  Adam J Lamble; Lisa Eidenschink Brodersen; Todd A Alonzo; Jim Wang; Laura Pardo; Lillian Sung; Todd M Cooper; E Anders Kolb; Richard Aplenc; Sarah K Tasian; Michael R Loken; Soheil Meshinchi
Journal:  J Clin Oncol       Date:  2021-12-02       Impact factor: 44.544

5.  Comprehensive Transcriptome Profiling of Cryptic CBFA2T3-GLIS2 Fusion-Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study.

Authors:  Jenny L Smith; Rhonda E Ries; Tiffany Hylkema; Todd A Alonzo; Robert B Gerbing; Marianne T Santaguida; Lisa Eidenschink Brodersen; Laura Pardo; Carrie L Cummings; Keith R Loeb; Quy Le; Suzan Imren; Amanda R Leonti; Alan S Gamis; Richard Aplenc; E Anders Kolb; Jason E Farrar; Timothy J Triche; Cu Nguyen; Daoud Meerzaman; Michael R Loken; Vivian G Oehler; Hamid Bolouri; Soheil Meshinchi
Journal:  Clin Cancer Res       Date:  2019-11-12       Impact factor: 12.531

6.  Impact of age on the survival of pediatric leukemia: an analysis of 15083 children in the SEER database.

Authors:  Yaping Wang; Jie Huang; Liucheng Rong; Peng Wu; Meiyun Kang; Xuejie Zhang; Qin Lu; Yongjun Fang
Journal:  Oncotarget       Date:  2016-12-13

7.  Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531.

Authors:  Andrew P Voigt; Lisa Eidenschink Brodersen; Todd A Alonzo; Robert B Gerbing; Andrew J Menssen; Elisabeth R Wilson; Samir Kahwash; Susana C Raimondi; Betsy A Hirsch; Alan S Gamis; Soheil Meshinchi; Denise A Wells; Michael R Loken
Journal:  Haematologica       Date:  2017-09-07       Impact factor: 9.941

8.  Acute Myeloid Leukemia with RAM Immunophenotype: A Pediatric Case with Unusual Morphologic Features.

Authors:  Miriam Conces; Rolla Abu-Arja; Suzanne Reed; Hemalatha G Rangarajan; Terri L Guinipero; Michael R Loken; Lisa Eidenschink Brodersen; Samir B Kahwash
Journal:  Hematol Rep       Date:  2017-06-14

Review 9.  CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity.

Authors:  Riccardo Masetti; Salvatore N Bertuccio; Andrea Pession; Franco Locatelli
Journal:  Br J Haematol       Date:  2018-12-28       Impact factor: 6.998

10.  Development and characterization of a DNA aptamer for MLL-AF9 expressing acute myeloid leukemia cells using whole cell-SELEX.

Authors:  Kaylin G Earnest; Erin M McConnell; Eman M Hassan; Mark Wunderlich; Bahareh Hosseinpour; Bianca S Bono; Melissa J Chee; James C Mulloy; William G Willmore; Maria C DeRosa; Edward J Merino
Journal:  Sci Rep       Date:  2021-09-27       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.